United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66267-153_1f98cfb6-fa4d-2288-e063-6294a90a4de7
- Product NDC
- 66267-153
- Form
- TABLET
- Composition / generic term
- Naproxen
- Labeler
- NuCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070701
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (66267-153-10) · 66267-153-10
- 14 TABLET in 1 BOTTLE (66267-153-14) · 66267-153-14
- 15 TABLET in 1 BOTTLE (66267-153-15) · 66267-153-15
- 20 TABLET in 1 BOTTLE (66267-153-20) · 66267-153-20
- 30 TABLET in 1 BOTTLE (66267-153-30) · 66267-153-30
- 40 TABLET in 1 BOTTLE (66267-153-40) · 66267-153-40
- 42 TABLET in 1 BOTTLE (66267-153-42) · 66267-153-42
- 60 TABLET in 1 BOTTLE (66267-153-60) · 66267-153-60
- 90 TABLET in 1 BOTTLE (66267-153-90) · 66267-153-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →